Description
Ailar (Insulin Glargin) Solution for Injections 100 IU/ml. 3 ml. Cart.№5
Ingredients:
Each milliliter contains 100 International Units of insulin glargine.
Mechanism of Action:
Insulin glargine works by mimicking the natural insulin produced by the body. It has a long duration of action, providing a steady level of insulin to help regulate blood sugar levels.
Pharmacological Properties:
Ailar is a long-acting insulin analog that forms microprecipitates at the injection site, resulting in a slow and continuous release of insulin into the bloodstream. This sustained release profile helps in maintaining stable glycemic control over 24 hours.
Indications for Use:
Ailar is indicated for the treatment of diabetes mellitus in both adults and children. It is used to help control blood sugar levels throughout the day and night.
Contraindications:
Do not use Ailar if you have a known allergy to insulin glargine or any of the components in the product. It is essential to consult with a healthcare provider before initiating treatment with Ailar, especially if you have other medical conditions or are taking other medications.
Side Effects:
Common side effects of Ailar may include hypoglycemia, injection site reactions, allergic reactions, and lipodystrophy. It is important to monitor blood sugar levels regularly and report any unusual symptoms to your healthcare provider.
Usage Instructions:
Administer Ailar subcutaneously once daily at the same time each day. The injection can be given into the thigh, abdomen, or deltoid region. Rotate injection sites to prevent lipodystrophy and ensure proper absorption of the medication.
Benefits Compared to Analogues:
Ailar offers the advantage of a long duration of action, allowing for once-daily dosing and providing consistent blood sugar control. Compared to short-acting insulins, Ailar offers a more stable and sustained release of insulin, reducing the risk of hypoglycemia and offering greater convenience to patients.
Suitable Patient Groups:
Ailar is suitable for use in both pediatric and geriatric populations. It is safe and effective for children and older adults who require basal insulin therapy to manage their diabetes.
Storage and Shelf Life:
Store Ailar in the refrigerator at a temperature between 36°F to 46°F (2°C to 8°C). Do not freeze. Once opened, the product can be stored at room temperature (59°F to 86°F or 15°C to 30°C) for up to 28 days. Discard any unused portion after the expiration date printed on the carton.
Packaging Description:
Ailar is available in cartons containing 5 prefilled disposable pens, each delivering 3 ml of the solution for injections at a concentration of 100 IU/ml. The pens are designed for easy and convenient use, allowing for accurate dosing and administration.
Clinical Evidence and Proven Effectiveness:
Studies have shown that Ailar, with its long-acting insulin glargine formulation, provides effective glycemic control in patients with diabetes. Research published in the Journal of Diabetes Science and Technology demonstrated that insulin glargine significantly reduced HbA1c levels compared to other insulins. Clinical trials have highlighted the safety and efficacy of Ailar in maintaining stable blood glucose levels over an extended period.
